Early Life Stress, Brain Development, and Obesity Risk: Is Oxytocin the Missing Link?

dysfunctional eating eating disorders energy homeostasis hypothalamus lactation leptin postnatal development trauma

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
11 02 2022
Historique:
received: 24 12 2021
revised: 05 02 2022
accepted: 08 02 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 9 4 2022
Statut: epublish

Résumé

Obesity disease results from a dysfunctional modulation of the energy balance whose master regulator is the central nervous system. The neural circuitries involved in such function complete their maturation during early postnatal periods, when the brain is highly plastic and profoundly influenced by the environment. This phenomenon is considered as an evolutionary strategy, whereby metabolic functions are adjusted to environmental cues, such as food availability and maternal care. In this timeframe, adverse stimuli may program the body metabolism to maximize energy storage abilities to cope with hostile conditions. Consistently, the prevalence of obesity is higher among individuals who experienced early life stress (ELS). Oxytocin, a hypothalamic neurohormone, regulates the energy balance and modulates social, emotional, and eating behaviors, exerting both central and peripheral actions. Oxytocin closely cooperates with leptin in regulating energy homeostasis. Both oxytocin and leptin impact the neurodevelopment during critical periods and are affected by ELS and obesity. In this review article, we report evidence from the literature describing the effect of postnatal ELS (specifically, disorganized/inconstant maternal care) on the vulnerability to obesity with a focus on the role of oxytocin. We emphasize the existing research gaps and highlight promising directions worthy of exploration. Based on the available data, alterations in the oxytocin system may in part mediate the ELS-induced susceptibility to obesity.

Identifiants

pubmed: 35203274
pii: cells11040623
doi: 10.3390/cells11040623
pmc: PMC8870435
pii:
doi:

Substances chimiques

Leptin 0
Oxytocin 50-56-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Endocrinology. 1999 Jun;140(6):2755-62
pubmed: 10342866
Cell. 2008 Oct 3;135(1):61-73
pubmed: 18854155
Nutr Res Rev. 2020 Dec;33(2):244-259
pubmed: 32115018
Regul Pept. 2006 Jul 15;135(1-2):7-11
pubmed: 16678285
Biol Psychiatry. 2022 Jan 1;91(1):36-42
pubmed: 33602500
Dis Model Mech. 2012 Sep;5(5):691-7
pubmed: 22773756
J Neuroendocrinol. 2015 May;27(5):335-42
pubmed: 25702774
Trends Neurosci. 2020 Mar;43(3):133-143
pubmed: 32101708
Science. 2021 Jul 2;373(6550):
pubmed: 34210852
Neuroreport. 2008 Jun 11;19(9):951-5
pubmed: 18520999
Regul Pept. 2004 Jun 15;119(1-2):39-44
pubmed: 15093695
Proc Natl Acad Sci U S A. 2019 Dec 16;:
pubmed: 31843930
Nat Rev Neurosci. 2018 Feb 16;19(3):153-165
pubmed: 29449715
Int J Mol Sci. 2021 Oct 24;22(21):
pubmed: 34768894
Horm Behav. 2020 Aug;124:104763
pubmed: 32407728
Obesity (Silver Spring). 2018 Jul;26(7):1117-1124
pubmed: 29656595
Oxid Med Cell Longev. 2020 Jan 24;2020:4309605
pubmed: 32082478
Front Neuroendocrinol. 2016 Jan;40:52-66
pubmed: 26616341
Clin Psychol Rev. 2021 Jun;86:101985
pubmed: 33770582
J Chem Neuroanat. 1990 Jul-Aug;3(4):271-6
pubmed: 2204355
Horm Behav. 2020 Nov;126:104855
pubmed: 32991888
PLoS One. 2012;7(9):e45167
pubmed: 23028821
Front Psychol. 2018 Feb 27;9:173
pubmed: 29535656
N Engl J Med. 2019 Dec 19;381(25):2440-2450
pubmed: 31851800
Biosci Biotechnol Biochem. 2007 Dec;71(12):3122-6
pubmed: 18071238
Biochem Biophys Res Commun. 1999 Mar 24;256(3):600-2
pubmed: 10080944
Psychol Bull. 2011 Nov;137(6):959-97
pubmed: 21787044
J Comp Neurol. 2018 Jan 1;526(1):133-145
pubmed: 28891045
Obes Rev. 2019 Jan;20(1):22-40
pubmed: 30253045
PLoS One. 2013 May 20;8(5):e61477
pubmed: 23700406
Front Endocrinol (Lausanne). 2015 Sep 07;6:138
pubmed: 26441828
Am J Physiol Gastrointest Liver Physiol. 2014 Oct 15;307(8):G848-62
pubmed: 25147234
Psychoneuroendocrinology. 2007 Jun;32(5):437-50
pubmed: 17433558
Ann N Y Acad Sci. 2017 Apr;1394(1):74-91
pubmed: 27508337
Nat Rev Endocrinol. 2017 Dec;13(12):700-709
pubmed: 28960210
Front Endocrinol (Lausanne). 2018 Jul 02;9:315
pubmed: 30013511
Dev Cogn Neurosci. 2020 Feb;41:100737
pubmed: 31786477
Nat Rev Endocrinol. 2020 Mar;16(3):177-189
pubmed: 32020062
Nat Rev Drug Discov. 2016 Jun;15(6):405-24
pubmed: 26965204
PLoS One. 2011;6(9):e25565
pubmed: 21980491
J Biosci. 2017 Mar;42(1):131-138
pubmed: 28229972
Neurosci Biobehav Rev. 2020 Mar;110:114-132
pubmed: 30172802
Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R87-96
pubmed: 15044184
J Clin Med. 2021 Aug 06;10(16):
pubmed: 34441780
Rev Endocr Metab Disord. 2021 Jun;22(2):241-255
pubmed: 33751362
Nat Neurosci. 2019 Jan;22(1):7-14
pubmed: 30531847
J Endocrinol. 2014 Feb 10;220(3):333-43
pubmed: 24389591
Nat Rev Endocrinol. 2018 Sep;14(9):513-537
pubmed: 30065268
Stress. 2015;18(3):328-42
pubmed: 26260665
Mol Cell Endocrinol. 2020 Aug 20;514:110903
pubmed: 32531419
J Psychiatr Res. 2018 Jun;101:80-103
pubmed: 29567510
Physiol Behav. 2020 Sep 1;223:113000
pubmed: 32512033
Endocrinology. 2014 Nov;155(11):4189-201
pubmed: 25157455
Brain Res. 2010 Sep 2;1350:2-9
pubmed: 20399755
Am J Physiol Endocrinol Metab. 2020 Nov 1;319(5):E852-E862
pubmed: 32830551
Science. 2004 Apr 2;304(5667):108-10
pubmed: 15064420
Psychoneuroendocrinology. 2017 Mar;77:186-195
pubmed: 28088658
PLoS One. 2013;8(3):e59625
pubmed: 23527232
Exp Gerontol. 2021 Nov;155:111561
pubmed: 34562568
Glia. 2019 Sep;67(9):1637-1653
pubmed: 31038797
Brain Res. 2008 Jun 18;1215:105-15
pubmed: 18485333
J Neuroendocrinol. 2002 May;14(5):349-53
pubmed: 12000539
Endocrinology. 2008 Oct;149(10):4892-900
pubmed: 18566122
Nat Metab. 2021 Jun;3(6):737-750
pubmed: 34158655
Neuropsychopharmacology. 2019 Mar;44(4):711-720
pubmed: 30188513
Neuroreport. 2011 Apr 20;22(6):259-63
pubmed: 21403582
Proc Nutr Soc. 2017 Aug;76(3):316-327
pubmed: 27903310
Science. 2004 Apr 2;304(5667):110-5
pubmed: 15064421
Stem Cells. 2008 Sep;26(9):2399-407
pubmed: 18583541
World J Gastroenterol. 2009 Apr 21;15(15):1869-75
pubmed: 19370785
Eur J Endocrinol. 2015 Aug;173(2):167-74
pubmed: 26142101
Dev Psychobiol. 2014 Dec;56(8):1675-88
pubmed: 24910169
N Engl J Med. 2018 Oct 04;379(14):1303-1312
pubmed: 30281992
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Brain Res. 2009 Oct 27;1295:127-34
pubmed: 19666012
Nutrients. 2021 Sep 24;13(10):
pubmed: 34684349
Elife. 2019 Jan 29;8:
pubmed: 30694175
Neuron. 2017 Aug 16;95(4):757-778
pubmed: 28817798
J Neuroendocrinol. 2020 Apr;32(4):e12805
pubmed: 31657509
J Lipid Res. 2013 Sep;54(9):2423-36
pubmed: 23836106
Trends Cogn Sci. 2017 Feb;21(2):80-99
pubmed: 28041836
Endocrinology. 2014 Apr;155(4):1340-52
pubmed: 24506069
Nat Rev Endocrinol. 2019 May;15(5):288-298
pubmed: 30814686
Nature. 1994 Dec 1;372(6505):425-32
pubmed: 7984236
Brain Res. 1979 Apr 13;165(2):249-60
pubmed: 421139
J Neuroendocrinol. 2000 Dec;12(12):1145-8
pubmed: 11106970
Psychodyn Psychiatry. 2017 Winter;45(4):499-517
pubmed: 29244625
Psychoneuroendocrinology. 2021 Jul;129:105247
pubmed: 33940517
Vitam Horm. 2005;71:27-58
pubmed: 16112264
Behav Brain Res. 2006 Jul 15;171(1):134-41
pubmed: 16677726
Behav Brain Res. 2020 Feb 3;379:112399
pubmed: 31790781
Obes Rev. 2017 Jul;18(7):715-723
pubmed: 28489290
J Clin Invest. 2017 Jan 3;127(1):43-54
pubmed: 28045398
Neuroscience. 2004;125(4):947-55
pubmed: 15120854
Int J Mol Sci. 2018 Dec 26;20(1):
pubmed: 30587816
J Neurosci. 2012 Nov 28;32(48):17097-107
pubmed: 23197703
Cell Metab. 2015 Dec 1;22(6):962-70
pubmed: 26603190
Physiol Rev. 2018 Jul 1;98(3):1805-1908
pubmed: 29897293
Int J Mol Sci. 2021 Jul 28;22(15):
pubmed: 34360816
Mol Cell Endocrinol. 2021 Aug 20;534:111381
pubmed: 34216640
Trends Pharmacol Sci. 2017 Nov;38(11):982-991
pubmed: 28899620
Nat Commun. 2019 Nov 8;10(1):5098
pubmed: 31704941
Psychoneuroendocrinology. 2018 Oct;96:203-211
pubmed: 30048914
Front Neuroanat. 2020 Oct 19;14:559402
pubmed: 33192340
Nutrients. 2018 Sep 04;10(9):
pubmed: 30181488
Aging (Albany NY). 2011 Dec;3(12):1169-77
pubmed: 22184277
Nature. 2015 Feb 12;518(7538):197-206
pubmed: 25673413
Science. 2017 Jun 16;356(6343):1185-1188
pubmed: 28619944
Int J Obes (Lond). 2018 Jul;42(7):1354-1365
pubmed: 29535450
Rev Endocr Metab Disord. 2022 Feb;23(1):87-101
pubmed: 33822303

Auteurs

Georgia Colleluori (G)

Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Tronto 10/A, 60020 Ancona, Italy.

Chiara Galli (C)

Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Tronto 10/A, 60020 Ancona, Italy.

Ilenia Severi (I)

Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Tronto 10/A, 60020 Ancona, Italy.

Jessica Perugini (J)

Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Tronto 10/A, 60020 Ancona, Italy.

Antonio Giordano (A)

Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Tronto 10/A, 60020 Ancona, Italy.
Center of Obesity, Marche Polytechnic University-United Hospitals, 60020 Ancona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH